These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 1171365

  • 1. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE, Reighlin S.
    N Engl J Med; 1975 Aug 28; 293(9):451-2. PubMed ID: 1171365
    [No Abstract] [Full Text] [Related]

  • 2. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA, Roland R, Lequin RM.
    Ned Tijdschr Geneeskd; 1975 Apr 05; 119(14):541-7. PubMed ID: 1170514
    [No Abstract] [Full Text] [Related]

  • 3. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ, Josimovich JB, Archer DF.
    Am J Obstet Gynecol; 1975 May 01; 122(1):85-9. PubMed ID: 1168997
    [Abstract] [Full Text] [Related]

  • 4. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG.
    South Med J; 1977 Jun 01; 70(6):720-1, 725. PubMed ID: 577621
    [Abstract] [Full Text] [Related]

  • 5. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Netter A, Netter AL, Gorins A.
    Gynecologie; 1975 Jun 01; 26(2):141-5. PubMed ID: 1164955
    [No Abstract] [Full Text] [Related]

  • 6. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP, Stone SC.
    Obstet Gynecol; 1976 Jul 01; 48(1):84-9. PubMed ID: 934580
    [Abstract] [Full Text] [Related]

  • 7. [Evolution of 15 pregnancies induced with bromocriptine therapy in patients with amenorrhea-galactorrhea].
    Campagnoli C, Belforte L, Bruno M, Fessia L, Pinna N, Massara F.
    Minerva Ginecol; 1980 May 01; 32(5):400-4. PubMed ID: 7393487
    [No Abstract] [Full Text] [Related]

  • 8. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M, Deodato M, Bramanti P, Volpe A, Grasso A, Di Perri R.
    Acta Neurol (Napoli); 1980 Feb 01; 2(1):15-22. PubMed ID: 7190350
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ, Geiger W, Schulz KD, Lose KH.
    Arch Gynakol; 1975 Feb 01; 218(2):85-94. PubMed ID: 1174026
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic usefulness of bromoergocriptine (CB-154 Sandoz) in patients with galactorrhea (author's transl)].
    González Colindres JA, Canales ES, Levinson G, Zárate A, Sorta J.
    Rev Invest Clin; 1975 Feb 01; 27(2):135-8. PubMed ID: 1237173
    [No Abstract] [Full Text] [Related]

  • 11. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
    Barreca P, Giannola C, Palisi F.
    Acta Eur Fertil; 1978 Mar 01; 9(1):21-9. PubMed ID: 567920
    [No Abstract] [Full Text] [Related]

  • 12. The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
    Sirbu P, Cioltei A, Simionescu L, Dumbravescu A, Sedan E, Titiriga L, Mîtulescu V.
    Acta Eur Fertil; 1979 Dec 01; 10(4):177. PubMed ID: 552769
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of the galactorrhea and amenorrhea syndrome associated with acromegaly using 2-bromine-alpha-ergocryptine].
    Durić DS, Dordević PB, Mićić JV, Popović SS.
    Srp Arh Celok Lek; 1977 Feb 01; 105(2):179-89. PubMed ID: 562001
    [No Abstract] [Full Text] [Related]

  • 14. Letter: Bromergocryptine and the galactorrhea-amenorrhea syndrome.
    Stempel LE.
    Ann Intern Med; 1976 Sep 01; 85(3):401-3. PubMed ID: 962235
    [No Abstract] [Full Text] [Related]

  • 15. [Pregnancy with thyroid replacement and additional bromocriptine therapy in a patient of amenorrhea-galactorrhea syndrome due to primary hypothyroidism (author's transl)].
    Matsuura K, Mizumoto J, Maeyama M.
    Acta Obstet Gynaecol Jpn; 1981 Feb 01; 33(2):305-8. PubMed ID: 7234339
    [No Abstract] [Full Text] [Related]

  • 16. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G, Schonauer S, Lodico G, Lotti G, Delitala G, Masala A.
    Minerva Ginecol; 1976 Oct 01; 28(10):761-70. PubMed ID: 1036769
    [Abstract] [Full Text] [Related]

  • 17. The amenorrhea galactorrhea syndrome.
    Ngan A, Wong WP.
    Singapore Med J; 1978 Sep 01; 19(3):132-7. PubMed ID: 751196
    [No Abstract] [Full Text] [Related]

  • 18. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C, Votino F, Mattera P, Montemagno U.
    Minerva Ginecol; 1979 Apr 01; 31(4):273-80. PubMed ID: 572516
    [No Abstract] [Full Text] [Related]

  • 19. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM, Siler-Khodr TM.
    J Clin Endocrinol Metab; 1976 Dec 01; 43(6):1398-401. PubMed ID: 1036743
    [Abstract] [Full Text] [Related]

  • 20. Bromocriptine. Clinical experience in the induction of pregnancy in amenorrhea-galactorrhea syndrome.
    Zárate A, Canales ES, Forsbach G, Fernández-Lazala R.
    Obstet Gynecol; 1978 Oct 01; 52(4):442-4. PubMed ID: 714326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.